Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism reprogramming to the heterogeneity of hepatocellular carcinoma (HCC) has not been ...

CLINICAL complete response (cCR) is a strong predictor of prognosis in patients with unresectable hepatocellular carcinoma ...

Nonalcoholic fatty liver disease (NAFLD ... and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis.

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

J Gastroenterol Hepatol. 2005;20(10):1478-1487. Lesions that might mimic FNH include adenoma (see description below), hepatocellular carcinoma (HCC), hypervascular metastases, and fibrolamellar HCC.

Researchers assessed the prognostic significance of older age and comorbidity burden on overall survival in patients with hepatocellular carcinoma.

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.